CCL2 and infection: In a mouse model of 2009 H1N1 pandemic influenza, the S1p1 receptor agonist significantly inhibited synthesis of IL-1α, IL-1β, IL-6, IL-10, MCP-1, TNF-α, and GM-CSF, and reduced deaths from lethal infections by more than 80%.